Pricing Log in Create free account

Actuate Therapeutics, Inc. (ACTU) vs Aspire-Lakewood Holdings, Inc. (ASBP)

Actuate Therapeutics, Inc. and Aspire-Lakewood Holdings, Inc. are both Biotechnology companies. Actuate Therapeutics, Inc. and Aspire-Lakewood Holdings, Inc. are of similar size ($12.1M and $12.0M). Actuate Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Aspire-Lakewood Holdings, Inc. trades at 0.2×. Actuate Therapeutics, Inc. has the higher net margin (0.00% vs −11,309.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Aspire-Lakewood Holdings, Inc. leads on 6 and Actuate Therapeutics, Inc. on 5.

Valuation

Metric ACTU ASBP Biotechnology median
P/E n/m 0.24 8.50
P/S n/m 93.27 9.71
P/B 14.72 0.78 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m (2.70) 9.21
Earnings yield (142.62%) 413.99% (33.15%)
Free cash flow yield (136.22%) (78.86%) (25.50%)

Profitability

Metric ACTU ASBP Biotechnology median
Gross margin — (24.97%) 65.16%
Operating margin 0.00% (7,491.61%) 0.00%
Net margin 0.00% (11,309.31%) 0.00%
Free cash flow margin 0.00% (7,355.07%) 0.00%
Return on equity 2,457.65% (1,032.15%) (56.36%)
Return on assets (336.18%) (152.09%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ACTU ASBP Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 67.48% (762.74%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric ACTU ASBP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.25 7.99 4.72
Net debt to EBITDA 0.59 (0.16) 0.96

Dividend

Metric ACTU ASBP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ACTU ASBP Biotechnology median
Market cap 12.01m 12.11m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack